Terapevticheskoe klonirovanie. Sovremennye podkhody k polucheniyu patsient-spetsifichnykh liniy embrional'nykh stvolovykh kletok



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Обзор посвящен актуальному биомедицинскому направлению в заместительной клеточной терапии - терапевтическому клонированию, которое является наиболее универсальным подходом для получения пациент-специфичных линий эмбриональных стволовых клеток СЭСЮ с колоссальными возможностями в поддержании и восстановлении здоровья человека. В обзоре также представлены альтернативные подходы и тенденции в получении ЭСК человека, которые, в отличие от терапевтического клонирования, пока далеки от выхода в клиническую практику. Уникальная ценность ЭСК в лечебных целях определяет серьезную потребность в развитии терапевтического клонирования и в нашей стране.

References

  1. Wilmut I., Schneider A.E., Chirr J. et al. Viable offspring derived from fetal and adult mammalian cells. Nature. 1997; 385[6619]: 810-3.
  2. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S. et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282[5391]: 1145-7.
  3. Shamblott M.J., Axelman J., Wang S. et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc. Natl. Acad. Sci. USA. 1998; 95[23]: 13726-31.
  4. He Q., Li J., Bettiol E., Jaconi M.E. Embryonic stem cells: new possible therapy for degenerative diseases that affect elderly people. J. Gerontol. A Biol. Sci. Med. Sci. 2003; 58[3]: 279-87.
  5. de Wert G., Mummery C. Human embryonic stem cells: research, ethics and policy. Hum. Reprod. 2003; 18[4]: 672-82.
  6. Hoffman D. I., Zellman G.L., Fair C.C. et al. Cryopreserved embryos in the United States and their availability for research. Fertil. Steril. 2003; 79[5]: 1063-9.
  7. Lyerly A.D., Faden R.R. Embryonic stem cells. Willingness to donate frozen embryos for stem cell research. Science. 2007; 317[5834]: 46-7.
  8. Nelson E., Mykitiuk R., Nisker J. et al. Informed consent to donate embryos for research purposes. J. Obstet. Gynaecol. Can. 2008; 30[9]: 824-36.
  9. Hug K. Motivation to donate or not donate surplus embryos for stem-cell research: literature review. Fertil. Steril. 2008; 89[2]: 263-77.
  10. Provoost V., Pennings G., De Sutter P. et al. Infertility patients' beliefs about their embryos and their disposition preferences. Hum. Reprod. 2009; 24[4]: 896-905.
  11. Hayden E.C. Obama overturns stem-cell ban. President's executive order will allow US human embryonic stem-cell research to thrive at last. Nature. 2009; 458[7235]: 130.
  12. Munsie M.J., Michalska A.E., O"Brien C.M. et al. Isolation of pluripotent embryonic stem cells from reprogrammed adult mouse somatic cell nuclei. Curr. Biol. 2000; 10[16]: 989-92.
  13. Rideout W.M. 3rd, Hochedlinder K., Kyba M. et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell. 2002; 109[1]: 17-27.
  14. Wobus A M., Boheler K.R. Embryonic stem cells: prospects for developmental biology and cell therapy. Physiol. Rev. 2005; 85[2]: 63578.
  15. Trounson A. The production and directed differentiation of human embryonic stem cells. Endocr. Rev. 2006; 27[2]: 208 - 19.
  16. Hochedlinger K., Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N. Engl. J. of Med. 2003; 349[3]: 275-86.
  17. Свиридова-Чайлахян Т.А., Чайлахян Л.М. Реконструкция зародышей мышей как адекватная модель для разработки основ терапевтического клонирования. ДАН. 2005; 404[3]: 422 - 4.
  18. Hwang W.S., Ryu Y.J., Park J.H. et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science. 2004; 303[5664]: 1669-74.
  19. Hwang W.S., Roh S.I., Lee B.C. et al. Patient-specific embryonic stem cells derived from human SCNT blastocysts. Science. 2005; 308[5755]: 1777-83.
  20. Revazova E.S , Turovets N.A., Kochetkova O.D. et al. Patient-specific stem cell lines derived from human parthenogenetic blastocysts. Cloning and Stem Cells. 2007; 9[3]: 432-9.
  21. French A.J., Adams C.A., Anderson L.S. et al. Development of human cloned blastocysts following somatic cell nuclear transfer with adult fibroblasts. Stem Cells. 2008; 26[2]: 485-93.
  22. Chen Y., He Z.X., Liu A. et al. Embryonic stem cell generated by nuclear transfer of human somatic nuclei into rabbit oocytes. Cell Res. 2003; 13[4]: 251-63.
  23. Li F., Cao H., Zhang Q. et al. Activation of human embryonic gene expression in cytoplasmic hybrid embryos constructed between bovine oocytes and human fibroblasts. Cloning Stem Cells. 2008; 10[3]: 297-306.
  24. Jingjuan, J., Tonghang, G., Xianhong, T. et al. Experimental cloning of embryos through human-rabbit interspecies nuclear transfer.Zool. Res. 2005; 26[4]: 416-21.
  25. Vogel, G. Stem cells: ethical oocytes, available for a price. Science. 2006; 313[5784]: 155.
  26. Chung Y., Bishop C.E., Treff N.R. et al. Reprogramming of human somatic cells using human and animal oocytes. Cloning Stem Cells. 2009; 11[2]. In print. <http://www.liebertonline.com/doi/abs/10.1089/clo.2009.0004>.
  27. John J.S., Lovell-Badge R. Human-animal cytoplasmic hybrid embryos, mitochondria, and an energetic debate. Nat. Cell Biol. 2007; 9[9]: 988-92.
  28. Bowles E.J., Lee J.H., Alberio R. et al. Contrasting effects of in vitro fertilization and nuclear transfer on the expression of mtDNA replication factors. Genetics. 2007; 176[3]: 1511-26.
  29. Miller R.A., Ruddle F.H. Pluripotent teratocarcinoma - thymus somatic cell hybrids. Cell. 1976; 9[1]: 45-55.
  30. Tada M., Takahama Y., Abe K. et al. Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr. Biol. 2001; 11[19]: 1553-8.
  31. Cowan C.A., Atienza J., Melton D.A., Eggan K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science. 2005; 309[5739]: 1369-73.
  32. Yu J., Vodyanik M.A., He P., Slukvin I.I., J.A. Thomson. Human embryonic stem cells reprogram myeloid precursors following cell-cell fusion. Stem Cells. 2006; 24[1]: 168-76.
  33. Do J.T., Scholer H.R. Nuclei of embryonic stem cells reprogram somatic cells. Stem Cells. 2004; 22[6]:941-9.
  34. Strelchenko N., Kukharenko V., Shkumatov A. et al. Reprogramming of human somatic cells by embryonic stem cell cytoplast. Reprod. Biomed. Online. 2006; 12[1]:107-11.
  35. Taranger C.K., Noer A., Sorensen A.L. et al. Induction of dedifferentiation, genome-wide transcriptional programming, and epigenetic reprogramming by extracts of carcinoma and embryonic stem cells. Mol. Biol. Cell. 2005; 16[12]: 5719-35.
  36. Matsumura H., Tada M., Otsuji T. et al. Targeted chromosome elimination from ES-somatic hybrid cells. Nat. Methods. 2007; 4[1]:23-5.
  37. Matsumura H, Tada T. Cell fusion-mediated nuclear reprogramming of somatic cells. Reprod. Biomed. Online. 2008; 16[1]: 51-6.
  38. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126[4]: 663-76.
  39. Nakagawa M., Koyanagi M., Tanabe K. et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 2008; 26[1]: 101-6.
  40. Yamanaka S. Strategies and new developments in the generation of patient-specific pluripotent stem cells. Cell Stem Cell. 2007; 1[1]: 39-49.
  41. Zaehres H., Schöler H.R. Induction of pluripotency: from mouse to human. Cell. 2007; 131[5]: 834-5.
  42. Nishikawa S.I., Goldstein R.A., Nierras C.R. The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell Biol. 2008; 9[9]: 725-9.
  43. Lowry W.E., Richter L., Yachechko R. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl. Acad. Sci. U S A. 2008; 105[8]: 2883-8.
  44. Park I.H., Zhao R., West J.A. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451[7175]: 141-6.
  45. Huangfu D., Osafune K., Maehr R. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nat. Biotechnol. 2008; 26[11]: 1269-75.
  46. Aasen T., Raya A., Barrero M.J. et al. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat. Biotechnol. 2008; 26[11]: 1276-84.
  47. Kim J.B., Zaehres H., Wu G. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature. 2008; 454[7204]: 646 - 50.
  48. Feng B., Jiang J., Kraus P. et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat. Cell Biol. 2009; 11[2]: 197 - 203.
  49. Kaji K., Norrby K., Paca A. et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature. 2009; In print. <http://www.nature.com/nature/journal/vaop/ncurrent/abs/nature07864.html>.
  50. Liu S.V. iPS cells: a more critical review. Stem Cells Dev. 2008; 17[3]: 391-7.
  51. Чайлахян Л.М., Свиридова-Чайлахян Т.А. Клеточная инженерия. Наука в России. 2001; 2: 10-5.
  52. Киселев С.Л., Волчков П., Филоненко Е. и соавт. Молекулярная и клеточная биология линий эмбриональных стволовых клеток человека. Молекулярная медицина. 2006; 2: 6-11.
  53. Karmenyan A., Shakhbazyan A., Sviridova-Chailakhyan T. et al. Setup picosecond infrared laser for micromanipulation of early mammalian embryos. In: Inst. of Biophotonics, National Yang-Ming University, editors. LALS-2008. Proceedings of the International Conference on Laser Application in Life Sciences; 2008 Decemb 4-6; Taiwan, Taipei; 2008: 184.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2009 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies